Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism
1 other identifier
observational
42
1 country
1
Brief Summary
This study is a cross-sectional study to explore the endocrine metabolism and inflammatory characteristics of the offspring of mothers with PCOS hyperandrogenism, in order to provide a theoretical basis for finding the cause of PCOS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2024
CompletedFirst Submitted
Initial submission to the registry
April 7, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedApril 17, 2024
April 1, 2024
10 months
April 7, 2024
April 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Testosterone
Testosterone is one of the androgens, which can be used to assess androgen levels.
Within one year after neonatal cord blood collection.
Androstenedione
Androstenedione is one of the androgens, which can be used to assess androgen levels.
Within one year after neonatal cord blood collection.
Dehydroepiandrosterone Sulfate
Dehydroepiandrosterone Sulfate is one of the androgens, which can be used to assess androgen levels.
Within one year after neonatal cord blood collection.
Sex Hormone Hinding Globulin
Sex hormone-binding globulin, also known as testosterone-estradiol binding globulin, is a carrier of sex hormones and can reflect the level of sex hormones.
Within one year after neonatal cord blood collection.
Free Androgen Index
The free androgen index can reflect the biological activity of androgen.
Within one year after neonatal cord blood collection.
Fasting Insulin
Insulin is a hormone secreted by pancreatic beta cells that lowers blood glucose and produces energy metabolism. Its level can assist in the diagnosis of insulin resistance.
Within one year after neonatal cord blood collection.
White Blood Cell Count
The white blood cell count can assess the inflammatory status.
Within six hours of neonatal cord blood collection.
Neutrophil Count
Neutrophil count can be used to assess the inflammatory status.
Within six hours of neonatal cord blood collection.
High-sensitivity C-reactive Protein
High-sensitivity C-reactive protein can be used to assess the inflammatory status.
Within six hours of neonatal cord blood collection.
Interleukin-6
Interleukin (IL)-6 can be used to assess the inflammatory status.
Within one year after neonatal cord blood collection.
Study Arms (2)
HA Group
Maternal hyperandrogenism of PCOS women with full-term singleton delivery were selected, and umbilical cord blood of their newborns was collected.
Control Group
Healthy pregnant women with full-term singleton delivery were randomly selected, and umbilical cord blood of their newborns was collected.
Eligibility Criteria
The women selected into the study group were diagnosed with PCOS before pregnancy and were complicated with hyperandrogenism.
You may qualify if:
- The diagnosis of polycystic ovary syndrome patients must meet the Rotterdam criteria.
- Aged between 18 and 45 years old.
- The gestational age of delivery is between 37 and 41 weeks of gestation.
- Singleton pregnancy.
- Signed informed consent form.
You may not qualify if:
- Combined with reproductive organ malformations or chromosomal abnormalities.
- Combined with chronic diseases such as diabetes and hypertension.
- Combined with thyroid disease or other serious systemic diseases such as cardiovascular disease.
- Multiple pregnancy.
- Combined with congenital adrenal hyperplasia, Cushing\'s syndrome, hypertension Prolactinoma, and androgen-secreting tumor-related diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangdong Women and Children Hosptial
Guanzhou, Guangdong, 511400, China
Biospecimen
Cord Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Li Li, M.D.
Guangdong Women and Children Hospital
- PRINCIPAL INVESTIGATOR
Chen Yuan, Master
Guangdong Women and Children Hosptial
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director, Institute of Women's and Children's Health
Study Record Dates
First Submitted
April 7, 2024
First Posted
April 17, 2024
Study Start
May 1, 2023
Primary Completion
March 5, 2024
Study Completion
March 5, 2024
Last Updated
April 17, 2024
Record last verified: 2024-04